Chemotherapy of advanced and recurrent cervical carcinoma.
about
Phase II study of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervix.Knockdown of PLC-gamma-2 and calmodulin 1 genes sensitizes human cervical adenocarcinoma cells to doxorubicin and paclitaxel.Targeting phosphodiesterase 3B enhances cisplatin sensitivity in human cancer cells.Tumor-specific gene therapy for uterine cervical cancer using MN/CA9-directed replication-competent adenovirus.Inhibitory effect of snake venom toxin on NF-κB activity prevents human cervical cancer cell growth via increase of death receptor 3 and 5 expression.
P2860
Chemotherapy of advanced and recurrent cervical carcinoma.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Chemotherapy of advanced and recurrent cervical carcinoma.
@ast
Chemotherapy of advanced and recurrent cervical carcinoma.
@en
type
label
Chemotherapy of advanced and recurrent cervical carcinoma.
@ast
Chemotherapy of advanced and recurrent cervical carcinoma.
@en
prefLabel
Chemotherapy of advanced and recurrent cervical carcinoma.
@ast
Chemotherapy of advanced and recurrent cervical carcinoma.
@en
P1476
Chemotherapy of advanced and recurrent cervical carcinoma.
@en
P2093
Nordqvist SR
P2860
P304
P356
10.1002/(SICI)1098-2388(199904/05)16:3<247::AID-SSU10>3.0.CO;2-4
P577
1999-04-01T00:00:00Z